Document is current
Any future updates will be listed below
-
Authors
Wern, Johan
Söderquist, Bo https://orcid.org/0000-0001-5939-2932
Tevell, Staffan https://orcid.org/0000-0002-9213-9274
-
Funding
Funding for this research was provided by:
Örebro University
- License Information
-
More Information
Article History
Received: 3 March 2025
Accepted: 21 May 2025
First Online: 28 May 2025
Declarations
:
: B.S. has been a member of an advisory board at ADVANZ PHARMA, and has also received speaker’s fees from Correvio Pharma Corp and ADVANZ PHARMA. All other authors: none to declare.
: The authors declare no competing interests.
